Skip to content

Basic Toolbox for Lipedema Syndrome Assessment ("BATOLISA")

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513529-21-00
Enrollment
60
Registered
2024-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipedema, Lipoedema

Brief summary

1. To observe the fluorescence in the extracellular matrix surrounding the superficial lymphatic vessels.

Detailed description

To quantify the mean velocity of the bolus displacement between two reference points placed over the collectors 50mm apart., 2. To measure the occlusion pressure of the superficial lymphatic collectors (below 160mmHg).

Interventions

DRUGVERDYE 5 mg/ml poudre pour solution injectable

Sponsors

Universite Libre de Bruxelles
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
1. To observe the fluorescence in the extracellular matrix surrounding the superficial lymphatic vessels.

Secondary

MeasureTime frame
To quantify the mean velocity of the bolus displacement between two reference points placed over the collectors 50mm apart., 2. To measure the occlusion pressure of the superficial lymphatic collectors (below 160mmHg).

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026